Alnylam Pharmaceuticals
ALNY
#643
Rank
C$45.71 B
Marketcap
$353.16
Share price
-1.30%
Change (1 day)
73.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $435.84 CAD on 2024-10-16

Lowest end of day price: $5.73 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$25.68-6.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$993.16-1.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$146.78-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.54 0.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.83-6.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$160.42 1.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$81.96 3.76%๐Ÿ‡ซ๐Ÿ‡ท France
$23.20-2.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel